
1 

(1) These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2024 and shall come into operation on 27th March 2024.
(2) The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.
2 

(1) The Misuse of Drugs Regulations (Northern Ireland) 2002 are amended as follows.
(2) In paragraph 1(a) of Schedule 1 (Controlled Drugs subject to the requirements of Regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—
(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;
(b) after “Bufotenine” insert “Butonitazene”;
(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;
(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;
(e) after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—“DiphenidineEphenidineEthyleneoxynitazene”;
(f) after “Etizolam” insert—“Etodesnitazene (etazene)Etonitazene”;
(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;
(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;
(i) after “Methcathinone” insert “Methoxyphenidine”;
(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—“Metodesnitazene (metazene)Metonitazene”;
(k) after “Propylphenidate” insert “Protonitazene”;
(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—“N-Desethyl etonitazeneN-DesethylisotonitazeneN-Desethyl protonitazene”;
(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—“N-Piperidinyl-etonitazene (etonitazepipne)N-Pyrrolidino-etonitazene (etoniazepyne)N-Pyrrolidino protonitazene”.
(3) In paragraph 1 of Schedule 2 (Controlled Drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.
(4) In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam”.
Sealed with the Official Seal of the Department of Health on 6th March 2024.
(L.S.)Cathy Harrison
A senior officer of the Department of Health
